 |
Q&A: The future of stem cell research (Dr. Zandstra)
01/12/2011 - Already in clinical use through therapies such as bone-marrow transplants and cartilage repair, regenerative medicine has only started to realize its potential. Although scientists may eventually use stem cells and biomaterials to cure everything from heart disease to neurodegenerative illnesses, developing and commercializing these technologies will take time. |
 |
Body Rebuilding: Researchers Regenerate Muscle Tissue in Mice
01/12/2011- A team of scientists from Worcester Polytechnic Institute (WPI) and CellThera, a private company located in WPI's Life Sciences and Bioengineering Center, have regenerated functional muscle tissue in mice, opening the door for a new clinical therapy to treat people who suffer major muscle trauma.
|
 |
Lab-grown glands, eyes and brain parts
04/12/2011 In the latest of a series of remarkable studies, researchers from the RIKEN Center for Developmental Biology in Kobe, Japan report that embryonic stem cells grown under special conditions can spontaneously organize themselves into a partial pituitary gland that is fully functional when transplanted into mice. |
 |
AlphaMed Press Launches New Journal: STEM CELLS TRANSLATIONAL MEDICINE
07/12/2011 - British, Israeli experts gather in Beersheba to join forces in finding cures for major diseases. A delegation of 60 British top academics will visit Israel this week to launch a groundbreaking program to promote collaboration between the two countries in regenerative medicine. |
 |
Xeltis Announces Approval to Begin First Clinical Study of Its Tissue-Engineered Vascular Grafts
07/12/2011- Xeltis, a biomedical technology company developing growing, living and self-healing cardiovascular implants using tissue-engineering technology, has announced conditional approval by the Paul Erlich Institute (PEI) in Germany to commence the first clinical study of its tissue-engineered cardiovascular grafts. The prospective, single-center study will evaluate the safety and efficacy of Xeltis' autologous tissue-engineered vascular grafts in pediatric patients requiring completion of a total cavo-pulmonary connection (TCPC). Sponsored by the University of Zurich, the trial will include up to 10 patients and will be performed at Heart Center Leipzig, Germany (HZL). |
 |
BioRestorative Therapies Signs Material Manufacturing Agreement With University of Utah
08/12/2011 - BioRestorative Therapies, Inc. (OTCQB: BRTX) ("BRT") today announced that it has entered into a Material Manufacturing Agreement with the University of Utah. Pursuant to the agreement, the University of Utah has been retained to manufacture certain materials derived from stem cells.
The agreement marks the next step in the development of a strategic collaboration between BRT and the University of Utah, an institution recognized as a leader in translational stem cell-based therapies.
|
|
Biomaterials' Role in Tissue Engineering (MD Marc Hendricks)
12/12/2011 - In this four-part discussion with MD+DI, Marc Hendriks, R&D and technology director at DSM Biomedical (Maastricht, Netherlands), discusses his thoughts on biomaterials. In this feature, the first of a four-part feature, Hendriks discusses biomaterails' ability to respond to the future needs of medical applications. at DSM Biomedical (Maastricht, Netherlands) muses on the importance of biomaterials in tissue engineering—both new and in years to come. Hendriks also explains what he describes as the "three generations of biomaterials." |
|
Bio-Assembling in 3-D with Magnetic Levitation
14/12/2011 - Growing tissues on two-dimensional petri dishes is so last century, say proponents of 3-D tissue engineering, who argue convincingly that the body isn't flat, and the experimental platforms and treatments of the future shouldn't be, either. Now a new technology, pioneered by Houston-based n3D Biosciences, promises to float cells in a 3-D matrix made of nothing but magnetism. |
 |
Hydrogel Helps Grow New, Scar-free Skin For 3rd Degree Burn Patients
14/12/2011 - Johns Hopkins researchers have developed a jelly-like material and wound treatment method that, in early experiments on skin damaged by severe burns, appeared to regenerate healthy, scar-free tissue.. |
 |
Tissue Engineering and Regeneration: Technologies and Global Markets
25/12/2011 - The global market for tissue engineering and regeneration products reached $55.9 billion in 2010, is expected to reach $59.8 billion by 2011, and will further grow to $89.7 billion by 2016 at a compounded annual growth rate (CAGR) of 8.4%.
|
